Trademark Attorney / Law Firm
Josh M. Gerben – Trademark Portfolio
Josh M. Gerben has 7 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 1 trademark is successfully registered — a 100% registration rate, with an additional 6 applications currently pending. The strongest areas of practice include Class 5 (Pharmaceuticals) and Class 25 (Clothing).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Josh M. Gerben's trademark practice covers 8 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Advertising; business management; business administration; office functions
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademark applications has Josh M. Gerben filed?
Josh M. Gerben has filed 7 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 6 pending.
What trademark classes does Josh M. Gerben specialize in?
Josh M. Gerben has filed trademarks across 8 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 18 (Leather Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Josh M. Gerben's trademark registration success rate?
Josh M. Gerben has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 6 applications are pending review.